← Back to Search

Neuromodulation

Transcranial Direct Current Stimulation for Autism

N/A
Recruiting
Led By Catherine Stoodley, D.Phil.
Research Sponsored by American University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
All participants must be aged 18-35
All participants must have NIH Toolbox age-adjusted Cognitive Function Composite standard score ≥ 85
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 30min post-tdcs
Awards & highlights

Study Summary

This trial will study whether electrical stimulations to the cerebellum can help improve social and executive functioning in young adults with autism.

Who is the study for?
This trial is for right-handed, English-speaking adults aged 18-35 with or without autism. Participants must be able to consent and attend all sessions, have no metal in their body, no history of seizures or claustrophobia, and a cognitive function score ≥ 85. Those with autism need a confirmed diagnosis.Check my eligibility
What is being tested?
The study tests the effects of transcranial direct current stimulation (tDCS) on social and executive functions in young adults with and without autism by applying mild electrical currents to the cerebellum during MRI scans.See study design
What are the potential side effects?
Potential side effects from tDCS may include temporary discomfort at the stimulation site like itching or tingling, headache, fatigue, nausea or irritability. Serious side effects are rare but can include seizures.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 35 years old.
Select...
My cognitive function score is 85 or higher.
Select...
I can attend all required study sessions.
Select...
I am a native English speaker.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 30min post-tdcs
This trial's timeline: 3 weeks for screening, Varies for treatment, and within 30min post-tdcs for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Cyberball social ball-playing task
Flexible Item Selection Test
Functional MRI data
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Right cerebellumExperimental Treatment1 Intervention
Participants (neurotypical, autistic) in this arm will receive tDCS targeting the right posterolateral cerebellum (lobule VII). All participants will receive anodal, cathodal and sham tDCS.
Group II: Posterior vermisExperimental Treatment1 Intervention
Participants (neurotypical, autistic) in this arm will receive tDCS targeting the posterior cerebellar vermis. All participants will receive anodal, cathodal and sham tDCS.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Transcranial direct current stimulation
2012
Completed Phase 3
~650

Find a Location

Who is running the clinical trial?

National Institute of Mental Health (NIMH)NIH
2,786 Previous Clinical Trials
2,689,619 Total Patients Enrolled
81 Trials studying Autism Spectrum Disorder
40,272 Patients Enrolled for Autism Spectrum Disorder
National Institutes of Health (NIH)NIH
2,701 Previous Clinical Trials
7,506,796 Total Patients Enrolled
20 Trials studying Autism Spectrum Disorder
2,366 Patients Enrolled for Autism Spectrum Disorder
American UniversityLead Sponsor
19 Previous Clinical Trials
4,685 Total Patients Enrolled

Media Library

Transcranial direct current stimulation (Neuromodulation) Clinical Trial Eligibility Overview. Trial Name: NCT05396352 — N/A
Autism Spectrum Disorder Research Study Groups: Right cerebellum, Posterior vermis
Autism Spectrum Disorder Clinical Trial 2023: Transcranial direct current stimulation Highlights & Side Effects. Trial Name: NCT05396352 — N/A
Transcranial direct current stimulation (Neuromodulation) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05396352 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this experiment currently recruiting participants?

"Affirmative. Per the information presented on clinicaltrials.gov, this medical trial is currently recruiting patients. It was first posted on January 1st 2022 and edited most recently in May 27th of the same year; aiming to enrol 80 participants at one location."

Answered by AI

Are seniors aged 75 and older eligible for participation in the research?

"As stated in the inclusion criteria, only those aged 18-35 are eligible to enroll in this medical trial."

Answered by AI

How extensive is the patient participation in this clinical investigation?

"Affirmative. Information found on clinicaltrials.gov implies that this research project is currently in the process of patient recruitment, beginning with a post date of January 1st 2022 and latest update occurring May 27th 2022. A total of 80 patients need to be enrolled at one centre."

Answered by AI

Could I be a part of this experiment based on my qualifications?

"Hopeful participants of this trial must meet two standards: they should have autism spectrum disorder and be between 18-35 years old. Altogether, there are 80 available spaces for enrolment."

Answered by AI

Who else is applying?

What state do they live in?
New York
Pennsylvania
How old are they?
18 - 65
What site did they apply to?
American University
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria

How responsive is this trial?

Typically responds via
Email
Most responsive sites:
  1. American University: < 48 hours
Average response time
  • < 2 Days
Recent research and studies
clinicaltrials.govStudy
Cerebellum and Autism: Regional Specialization for Social and Executive Functions
Catherine Stoodley 2022. "Cerebellum and Autism: Regional Specialization for Social and Executive Functions". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05396352.
All > Asd > Autism
~18 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top